Similarly, in the MR analysis of the other 56 SNPs, a 1-unit increase in the log-transformed genetically elevated CRP was associated with about 20% reduced risk for breast cancer among women who had used OC for <5 years (Figure 3); the estimates remained consistent in the second stage of MR analysis after excluding pleiotropic SNPs. This evidence concerns the gene CRP and breast cancer.